A significant breakthrough in the understanding of sleep mechanism opens new promise for treating sleep disorders and associated neuropsychiatric conditions: Scientists have pinpointed the melatonin ...
A significant breakthrough in the understanding of sleep mechanism opens new promise for treating sleep disorders and associated neuropsychiatric conditions: Scientists have pinpointed the melatonin ...
Scientists have identified the melatonin MT1 receptor as a key regulator of REM sleep, crucial for memory, dreaming, and ...
With fresh, positive data in hand, Biohaven now believes its medicine could be the first to receive FDA approval for spinocerebellar ataxia.
Parkinson's comes on slowly, and diagnosing the often-devastating movement disorder, particularly in its early stages, ...
Johns Hopkins launches OneNeuro, a cross-disciplinary initiative to utilize emerging technologies and AI to finally crack the code on the enigmatic human brain ...
HealthDay on MSN3d
Study Reveals No Link Between HDL Cholesterol and Movement DisordersThere is no correlation between high-density lipoprotein cholesterol (HDL-C) levels and a patient's risk for developing ...
If you watch her documentary Jane Fonda in Five Acts or read her autobiography and her books on aging and climate change, ...
There is no correlation between high-density lipoprotein cholesterol (HDL-C) levels and a patient's risk for developing ...
Analyst Jason McCarthy from Maxim Group reiterated a Buy rating on Gain Therapeutics (GANX – Research Report) and keeping the price ...
Researchers evidence suggests it’s the lessening of amyloid-beta in the brain that is behind cognitive decline.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback